References
- Brown DW, Gieles WH, Croft JB. Left ventricular hyper-trophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000; 140: 848–56.
- Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334–41.
- Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithe11 HO. Echocardiographic and electrocardiographic diagnoses of ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346–51.
- Agabiti-Rosei, Lorenza ML. Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues. Blood Press 2001; 10: 288–98.
- Simone G, Palmieri V. Left ventricular hypertrophy in hypertension as a predictor of coronary events: relation to geometry. Curr Opin Nephrol Hypertens 2002; 11: 215–20.
- Cuspidi C, Macca G, Michev I, et al. Left ventricular con-centric remodelling and extracardiac target organ damage in essential hypertension. J Hum Hypertens 2002; 16: 385–90.
- Benjamin EJ, Levy D. Why is left ventricular hypertropy so predictive of morbidity and mortality? Am J Med Sci 1999; 317: 168–75.
- Stanton AV, Mayet J, Chapman N, Foale RA, Hughes AD, Thom SA. Ethnic differences in carotid and left ventricular hypertrophy. J Hypertens 2002; 20: 539–43.
- Shipilova T, Pshenichnikov I, Kaik J, et al. Arterial hyper-tension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population. Blood Press 2003; 12: 12–18.
- Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, CasteIli WP. Echocardiographic criteria for left ven-tricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956–60.
- Coca A, Gabriel R, de la Figuera M, et al. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. Ventriculo Izquierdo Tension Arterial Espana. J Hypertens 1999; 17: 1471–80.
- Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population; The Tromso Study. Eur Heart J 1999; 20: 429–38.
- Sriratanasathavorn C, Buripanyo K, Mahanonda N, et al. The prevalence of left ventricular hypertrophy and asso-ciated factors in a Thai population. J Med Assoc Tai 2000: S218–22.
- Chien KL, Sung FC, Hsu HC, Su TC, Lee YT. Left ventricular mass and correlated atherosclerotic risk factors in young adolescents: report from Chin-Shan community cardiovascular study in Taiwan. Atherosclerosis 2001; 155: 431–7.
- Andren B, Lind L, Hedenstierna G, Lithe11 H. Left ven-tricular hypertrophy and geometry in a population sample of elderly males. Eur Heart J 1996; 17: 1800–7.
- Tingleff J, Munch M, Jakobsen TJ, et al. Prevalence of left ventricular hypertrophy in a hypertensives population. Eur Heart J 1996; 17: 143–9.
- Hessen WF, Beltman FW, May JF, et al. High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hyperten-sion 1997; 29: 539–43.
- Wirth A. Hypertension and cardiomyopathy in obesity. Treat the heart simultaneously. MMW Fortschr Med 2001; 18: 39–42.
- Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass the Tecumseh Blood Pressure Study. Circulation 1994; 90: 928–36.
- Saba MM, Ibrahim MM, Rizk HH. Gender and the relationship between resting heart rate and left ventricular geometry. J Hypertens 2001; 19: 367–73.
- Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens 2000; 14: 83–90.
- Sundstrom J, Lind L, Vessby B, Andrin B, Aro A, Lithell HO. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circula-tion 2001; 103: 836–44.